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Abstract  
In this case study, a coxsackievirus A5 (Picornaviridae) and a norovirus GII.4 
(Caliciviridae) co-infection were detected using RT-PCR from a faecal sample of a 6-year-old 
girl with symptoms of severe acute encephalopathy subsequently diagnosed as intermittent 
form of maple syrup urine disease (MSUD). The two co-infecting viruses were hiding and 
triggering the underlying metabolic disorder. The genotyping of the viruses as well as the 
chronological course, wide spectra of laboratory tests and clinical presentations of this case 
which includes recurrent vomiting without diarrhoea, metabolic acidosis, unconsciousness, 
seizure and circulatory collapse, but with positive final outcome is also presented. 
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Maple syrup urine disease (MSUD) or branched-chain ketoaciduria is a rare but life-
threatening metabolic disorder of autosomal recessive inheritance named after the 
characteristic odour of affected infants' urine reminiscent of maple syrup [1]. The genetic 
background of MSUD contains multiple alterations in either branched chain α-ketoacid 
dehydrogenase (BCKDH) A, B or dihydrolipoamide branched chain transacylase (DBT) E2 
genes [2,3]. Mutational changes of BCKDH enzyme complex cause the elevation of the 
branched-chain amino acids (BCAA) including valine, isoleucine and leucine in the patient’s 
sera and eventually lead to metabolic crisis [2,3]. Based on the clinical manifestations MSUD 
patients can be classified into classical or different, non-classical phenotypes called 
intermediate, intermittent, thiamine-responsive, and dihydrolipoyl dehydrogenase (E3)-
deficient [2,3]. The untreated newborns with classical MSUD - which is the most common 
type - show various symptoms of CNS involvement a few days after birth. Children with the 
intermittent form manifest no symptoms, have average level of plasma BCAAs and normal 
physical growth therefore the presence of MSUD could remain hidden even for long time. 
The onset of non-classical form of MSUD is suggested to connect to various causes of 
physiologic stress including common bacterial or viral infections which could trigger the 
degradation of muscle proteins rich in BCAA [4,5]. During the MSUD induced metabolic 
crisis symptoms may include vomiting, dehydration, ketoacidosis, ketonuria, lethargy, rapid 
neurological decline including seizures and encephalopathy [3]. These resemble the 
symptoms of encephalitis which include altered mental state (e.g. disorientation, speech 
disturbances), focal or diffuse neurological signs, seizures, fever, and imaging (e.g. magnetic 
resonance - MRI) and/or electroencephalogram (EEG) consistent with encephalitis. Other 
common clinical features like headache and bouts of vomiting are often present, as is 
cerebrospinal fluid (CSF) pleocytosis [6]. The etiological background of encephalitis could 
include c.a. 100 different pathogens; most of them are viruses like parechoviruses, 
4 
enteroviruses (family Picornaviridae), herpesviruses (family Herpesviridae), arboviruses and 
a number of non-microbial processes like autoimmune (including acute disseminated 
encephalomyelitis - ADEM) and paraneoplastic encephalitis [6,7]. Furthermore most 
symptoms of metabolic crisis in MSUD can also be present in a severe, untreated 
gastroenteritis caused by e.g. noroviruses (NoV, family Caliciviridae), or rotaviruses (family 
Reoviridae). These symptoms are mostly due to the indirect effect (e.g. severe dehydration, 
electrolyte imbalance and acidosis) of the viral infection induced frequent diarrhoea and/or 
vomiting especially among children and the elderly [8-10]. The aim of this study was to show 
the clinical course of a 6-year-old patient with acute encephalopathy and metabolic crisis, 
subsequently diagnosed with intermittent form of MSUD, including the detailed chronological 
presentation of symptoms, diagnostic and therapeutic activities during the hospital stay. The 
patient had coxsackievirus A5 (family Picornaviridae) and norovirus GII.4 (family 
Caliciviridae) co-infection which triggered and masked, because of the overlapping clinical 
symptoms, the onset of an intermittent form of MSUD. They might have contributed to the 
severity of the metabolic crisis.  
On July 29, 2015 a 6-year-old euthermic and conscious girl was presented at the 
emergency room of Szent János Hospital (Budapest) with severe dehydration, dizziness and 
slurred speech. The patient’s symptoms started four days earlier with fever and vomiting but 
no diarrhoea (Fig. 1). Routine blood tests disclosed leukocytosis, hyponatraemia, slightly 
impaired renal function, metabolic acidosis and increased anion gap (Fig. 1). Parenteral fluid 
administration resulted in temporary improvement; however, the next morning she became 
unconscious and developed a seizure successfully stopped by benzodiazepine. Despite the use 
of furosemide and mannitol she remained unconscious. Mechanical ventilation was started, 
and the patient was transferred to the Pediatric Intensive Care Unit of Szent István and Szent 
László Hospital (Budapest) for suspected encephalitis. Intravenous acyclovir and ceftriaxone 
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were initiated. CSF protein and glucose levels and cell count were normal. Nasal, throat, 
tracheal swabs, urine, CSF and blood samples were taken for bacteriological and mycological 
diagnostics, but microbial pathogens were not detected. A mild circulatory impairment was 
stabilized by the administration of fluid, albumin and inotropic medication. Results of the 
blood test were returned to normal (Fig. 1). Upon neurological testing the pupils were wide 
but appropriately reacted to light, there was no optic disc congestion, and the child had no 
focal deficit. EEG showed severe diffuse dysfunction. ADEM could not be excluded and 
methylprednisolone was started. Cranial MRI showed symmetrical lesions of the brainstem, 
the thalami, the cortex and the cerebellar dentate nuclei (Fig. 2). This level of symmetry is 
uncommon in ADEM. Repeated MRI revealed regression of the lesions radiologically 
interpreted as of either viral, toxic or metabolic origin. Mass lesions, haemorrhage and 
ischemia could be excluded. As the disease seemed to be infection-related, faecal, serum, 
cerebrospinal fluid (CSF) and nasopharyngeal aspirate samples were collected for diagnostic 
purposes. Pathogenic microbes were not detected by bacteriological and mycological tests and 
cultures. Autoimmune encephalitis auto-antibodies against glutamate receptors (NMDA, 
AMPA1, AMPA2), CASPR2, LGI1, GABARB1/B2 and anti-aquaporin-4 antibodies were 
negative in serum and CSF. Adenovirus, HHV1/2 and Varicella-Zoster virus (VZV) DNAs 
were not detectable by PCR in either serum or CSF samples. Antibodies against tick-borne 
encephalitis virus and West Nile virus were not shown in the analyzed samples as well. Total 
RNA was extracted from the faecal, serum and cerebrospinal fluid (CSF) samples using TRI 
reagent® (MRC, USA) according to the manufacturer’s instructions. The presence of 
enterovirus and parechovirus was tested using RT-PCR and generic primer pairs targeting the 
5’UTR regions (enteroviruses: UnivEnt-5UTR-R: 5’-ATTGTCACCATAAGCAGCCA-3’ 
and UnivEnt-5UTR-F: 5’-GTACCYTTGTRCGCCTGTT-3’; parechoviruses: HPeV-5UTR-
Rgen: 5’-CCAGATCAGATCCATAGTGTC-3’ and HPeV-5UTR-Fgen: 5’-
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GATGGCGTGCCATAAYTCTA-3’. All specimens were negative for human parechovirus, 
but the faecal sample showed enterovirus positivity. Furthermore, a critical revision of the 
patient’s history with several bouts of vomiting raised the suspicion of gastrointestinal (GI) 
viral infection; therefore faecal sample was tested retrospectively for rotavirus/adenovirus 
using immunochromatographic assay (CerTest-Biotec, Zaragoza, Spain) and for norovirus by 
RT-PCR using the generic primer pairs of JV12Y (5'-ATACCACTATGATGCAGAYTA-3) 
and JV13I (5’-TCATCATCACCATAGAAIGAG-3’) targeting the RNA polymerase region 
[11]. The faecal sample was negative for rotavirus and adenovirus but positive for norovirus. 
Norovirus RNA was not detected in serum and CSF samples. The viral load of the detected 
enterovirus (2.36E+06/mL faeces) and norovirus (4.5E+07/mL faeces) were determined using 
SYBR Green-based real-time PCR assay (Maxima SYBR Green qPCR Master Mix, Thermo 
Scientific, USA). For the generation of standard curves ten-fold dilution series of silica-
column (Qiagen, Germany) purified and spectrophotometrically quantified RT-PCR 
amplicons of detected norovirus and enterovirus were used. These results suggest that 
norovirus and enterovirus co-infection was present during the ongoing severe encephalopathy.  
In the next few days there was a continuous improvement of the patient’s neurological 
condition. Her consciousness returned. The control EEG showed only mild alteration. The 
patient was weaned from ventilator and discharged from hospital 14 days after admission 
without neurological sequelae. Two and a half months later this girl was hospitalized again for 
acute onset of vomiting, ataxia, lethargy and disturbed consciousness in the context of a viral 
illness. Laboratory testing revealed abnormalities similar to those during the first episode. The 
recurrence of encephalopathy, acidosis and increased anion gap, the symmetrical MRI pattern 
made a metabolic disorder most likely. Tandem mass spectrometry (MS) was performed and 
detected significant elevation in serum levels of branched chain amino acids, especially of 
leucine. DNA sequencing of the BCKDH-B gene found a potential compound heterozygous 
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state for a known pathogenic variant (c.832G>A) on one allele and a likely pathogenic, so far 
not reported frameshift mutation (c.887_896dup) on the other, in accordance with the 
biochemical diagnosis of maple syrup urine disease (MSUD). The normal motor and 
cognitive development with episodes of encephalopathy during febrile infections is typical of 
the intermittent form of the disease. The child did not have further recurrences during the past 
18 months and her leucine, isoleucine and valine levels remained normal on a diet with 
restricted meat consumption. For the reliable typing the full-length genome of the detected 
enterovirus strain as well as the full capsid sequence of the detected norovirus strain were 
determined using RT-PCR and 5’/3’ RACE PCR methods with sequence-specific primer pairs 
[12,13]. The PCR products were sequenced directly in both directions with the BigDye 
Terminator Cycle Sequencing Kit (Applied Biosystems, Warrington, UK) and run on an 
automated sequencer (ABI PRISM 310; Applied Biosystems). The determined genomic 
sequences were deposited in the GenBank database under accession numbers of KU761262 
and KY341923. The sequence alignments and identity calculations were performed with the 
BioEdit software (version 7.1.3.0) using the ClustalW algorithm. The bootstrapped (1000 
replicates) neighbour joining method with the Jukes-Cantor matrix-based model was used to 
construct the VP1 phylogenetic tree of enterovirus nucleotide sequences by MEGA software 
ver. 6.06 [14]. The 7405-nt-long genome of CVA5/13164/HUN/2015 [KU761262] follows 
the general enterovirus genome layout and shows 92.5/98.3%, 92.7/98.6% and 92.5/98.7% 
nt/aa identities to the P1, P2 and P3 genome regions of coxsackievirus A5 strain 
CVA5/SD/CHN/09 (HQ728261) as the closest match identified by BLAST search. Based on 
the high sequence identity values CVA5/13164/HUN/2015 most likely belongs to the CV-A5 
genotype. Because of the small number of complete CV-A5 genomes (N=5) available to date 
the phylogenetic analysis of the study strain was restricted to the 314-nt-long partial VP1 
sequences of CV-A5 from which numerous sequences were available in the GenBank 
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database. In the VP1 phylogenetic tree the CVA5/13164/HUN/2015 is clustered together with 
several CV-A5 strains collected after 2006 with the closest phylogenetic relationship to strain 
NIV093891LV17 (JX476134) which was identified from a faecal sample originated from a 
patient with acute flaccid paralysis in India [15] (Fig. 3). These two sequences share 
95.8/100% nt/aa identity to each other. Based on the 3207-nt-long partial polymerase and 
complete capsid sequence, the detected norovirus strain Hu/GII.4/13164/2015/HUN 
[KY341923] belongs to the genogroup II (GII) with the closest sequence relative of GII.4 
genotype of norovirus strain Hu/GII.4/Sydney/NSW0514/2012/AU (JX459908) using the 
Norovirus Genotyping Tool Ver. 1.0 [16]. These two sequences share 98% nt identity at the 
corresponding regions. 
In this study, a coxsackievirus A5 and a norovirus GII.4 co-infection were detected 
from a faecal sample of a 6-year-old girl with symptoms of severe acute encephalopathy 
which was subsequently diagnosed as an intermittent form of maple syrup urine disease 
(MSUD). Furthermore the first complete genome of coxsackievirus A5 from Hungary was 
determined and characterized which is also the first complete CV-A5 genome originated from 
Europe. The identified norovirus strain belongs to the GII genogroup and shows closest 
relationship to a GII.4 genotype which was the predominant norovirus genotype circulating 
worldwide including Hungary in 2015 and could be associated with more severe outcomes 
than non-GII.4 strains [10]. Although the decisive diagnosis of MSUD (detection of high level 
of BCAAs in the patient’s serum by tandem MS) was conducted at the onset of the second 
episode, the presence of known and novel, likely pathogenic mutations in the BCKDH-B gene 
suggested that the first episode was also due to MSUD. This is supported by the observation 
that episodes of the intermittent form of MSUD are usually related to massive physiologic 
stress often triggered by bacterial or viral infection [4,5]. In our case this definitive trigger 
was most likely a NoV and CV-A5 co-infection. The non-classical types of MSUD usually 
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have their onset by the age of two years [4,5], but in the presented case MSUD remained 
hidden until the patient’s age of 6. This was most likely due to the lack of severe 
physiological stress until the co-infection caused by CV-A5 and NoV GII.4. The severity of 
the CV-A5 / NoV co-infection was suggested by the relatively high viral load found in the 
patent’s faeces collected a week after the onset of the GI symptoms. Usually the early 
diagnosis of late onset of non-classical MSUD is initially started by the recognition of 
atypical courses of common infections [5]. In cases where symptoms of the ongoing 
infection(s) and those of MSUD overlap, diagnosis could be incorrect and MSUD may remain 
undetected even in spite of typical symptoms. In the presented case, the symptoms 
accompanying the viral co-infection of CV-A5 and NoV-GII.4 could just as easily indicate 
the onset of an MSUD- related metabolic crisis [3]. Therefore these symptoms mimicked 
those of infection-related encephalitis, and only their reappearance at the second 
hospitalization turned attention to metabolic disorders. On metabolic screening MSUD was 
diagnosed and this was supported by the positive finding of DNA analysis. This intermittent 
form manifests with recurrent bouts of encephalopathy most likely triggered first by prior 
infections of CV-A5/NoV-GII.4.  
The CNS symptoms as well as the repeated bouts of vomiting without diarrhoea 
diverted the attention from a potential gastrointestinal disease therefore the NoV-infection 
was diagnosed later, after the detection of CV-A5. The lack of diarrhoea is common in 
norovirus-related gastroenteritis of children therefore in case of episodes of vomiting even 
without diarrhoea a possible norovirus infection should be kept in mind [10, 17].  
Though tandem mass spectrometry (MS/MS)-based amino acid profiling of serum and 
molecular detection of pathogenic variants of BCKDHA/B and DBT genes associated with 
MSUD are not part of routine diagnostics, in case of severe metabolic acidosis and CNS 
involvement the isoleucine and leucine levels should be tested regardless of the presence of 
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gastrointestinal infection [3]. We think this case study is a good example of multidisciplinary 
effort and continuous real-time revision of clinical thinking in a severe, life-threatening 
disease, where both the trigger and the underlying were finally identified.  
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Figure legends 
Fig. 1. Chronological summary of the clinical case. The horizontal black line with numbers 
represents days from July 25 to Aug 11, 2015. The symptoms (blocks with gray background) 
and actions (white blocks) are depicted under the date line. Horizontal grey arrows represent 
the durations of the drug treatments. The results of laboratory tests and clinical examinations 
are shown under the date line. Detailed discussion of the tests and examinations are found in 
the text. Abbreviations: n.d.: not determined, WBC: white blood cells, NEU: neutrophil 
granulocytes, MRS: magnetic resonance spectroscopy, CRP: C-reactive protein, Na: Sodium, 
KN: urea, bact. & mycol.: bacteriological and mycological, Virol. tests: virological tests, 
Prot.: Protein (unit: g/L) Glu: glucose (unit: mmol/L). PICU: Pediatric Intensive Care Unit, 
LP: lumbar puncture, CV-A5: coxsackievirus A5, NoV: norovirus. 
Fig. 2. Axial FLAIR (A-D) and diffusion-weighted images (DWI: E-H) of the patient show 
symmetrical areas of increased signal (arrows) involving the cerebral cortex (A), the thalami 
(B), the midbrain (C), the pons and the cerebellar dentate nuclei (D). Some of these lesions 
manifest restricted diffusion (high signal on DWIs: E, F and G). 
Fig. 3. Phylogenetic relationship of CVA5/13164/HUN/2015 (in bold and marked with an 
arrow) and the closest relatives of CV-A5 sequences (strain names followed by the accession 
numbers in square brackets, the country and year of isolation) based on the Neighbor-Joining 
tree of 314-nt-long partial VP1 sequences. CV-A5 strains with available complete genomes 
are underlined and marked with asterisk. Coxsackievirus A12 (CV-A12) strains were used as 
outgroup. Note that the CV-A5 strains identified after 2006 (≥2006) are clearly separated 
from strains isolated earlier (≤ 2003). 
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